All stock lists
Kimberly Clark Corp (NASDAQ:KMB)
US · Delayed Price · Currency is USD
Also listed: 0JQZ.L, KMY.DEConsumer Defensive · Household & Personal Products
109.56-0.59 (-0.54%)
Insider Score
––Not scored
KMB Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
KMB analyst forecast
KMB analyst consensus
Hold6 ratings
Buy 2 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
KMB 12-month price target
No published price targets in the last 12 months.
Best analysts covering KMB
- Citigroup63%success rate · 8 calls
- B of A Securities33%success rate · 3 calls
- Piper Sandler17%success rate · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
KMB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | BNP Paribas | Neutral | — | — | Reiterated | 2026-10-16 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-10-13 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-10-05 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-09-25 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-09-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-09-10 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-08-05 |
| — | UBS | Neutral | — | — | Reiterated | 2026-08-05 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-21 |
| — | UBS | Neutral | — | — | Reiterated | 2026-07-16 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-07-08 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-17 |
| — | UBS | Neutral | — | — | Reiterated | 2026-04-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-14 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-04-10 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-04-08 |
| — | UBS | Neutral | — | — | Reiterated | 2026-04-07 |
| — | Deutsche Bank | Hold | — | — | Reiterated | 2026-03-30 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-03-13 |
| — | UBS | Neutral | — | — | Reiterated | 2026-01-28 |
| — | UBS | Neutral | — | — | Reiterated | 2026-01-14 |
| — | Citigroup | Sell | — | — | Reiterated | 2026-01-14 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-01-08 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-01-05 |
| — | Citigroup | Sell | — | — | Reiterated | 2025-12-17 |
| — | BNP Paribas Exane | Neutral | — | — | Reiterated | 2025-12-01 |
| — | Argus Research | Buy | — | — | Upgraded | 2025-11-13 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-04 |
| — | TD Cowen | Hold | — | — | Reiterated | 2025-11-04 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2025-11-04 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-11-04 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-10-31 |
| — | TD Cowen | Hold | — | — | Reiterated | 2025-10-31 |
| — | UBS | Neutral | — | — | Reiterated | 2025-10-31 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-10-10 |
| — | Citigroup | Sell | — | — | Reiterated | 2025-10-09 |
| — | UBS | Neutral | — | — | Reiterated | 2025-10-08 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-10-02 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-10-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-09-25 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-09-22 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-08-04 |
| — | JP Morgan | Neutral | — | — | Upgraded | 2025-08-04 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-07-25 |
| — | UBS | Neutral | — | — | Reiterated | 2025-07-17 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-07-15 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-04-24 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-04-23 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-04-23 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-04-23 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-04-17 |
| — | UBS | Neutral | — | — | Reiterated | 2025-04-17 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-04-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-03-28 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-03-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-01-29 |
| — | UBS | Neutral | — | — | Reiterated | 2025-01-29 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-01-24 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-01-17 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-01-16 |
KMB earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-04-28 | 1.93 | 1.97 | $4.09B | $4.16B |
| 2026-08-04 | 2.01 | 1.80 | $4.22B | $4.19B |
| 2026-11-05 | 1.63 | 0.00 | $4.12B | $0 |
| 2027-01-27 | 1.65 | 0.00 | $4.13B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.